Omission of early thromboprophylaxis and mortality in critically ill patients: A multicenter registry study

Chest

Volumn 140, Issue 6, 2011, Pages 1436-1446

  Ho, Kwok M ^a   Chavan, Shaila ^b   Pilcher, David ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Australian and New Zealand Society of Intensive Care   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INSULIN;

ADULT; AGED; APACHE; ARTICLE; AUSTRALIA; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIABETES MELLITUS; EARLY INTERVENTION; FEMALE; HEART ARREST; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORTALITY; MULTIPLE TRAUMA; NEW ZEALAND; PREDICTION; PRIORITY JOURNAL; SEPSIS; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

EID: 83455163418     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1444     Document Type: Article

References (29)

1. Galson SK. The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism. US Department of Health and Human Services Web site. http://www.surgeongeneral.gov/topics/deepvein/. Accessed December 24, 2010.
2. National Quality Forum. National voluntary consensus standards for prevention and care of venous thromboembolism: additional performance measures. Executive summary 2008. National Quality Forum Web site. http:// www.qualityforum.org/Publications/2008/10/National-Voluntary- Consensus-Standards-for-Prevention-and-Care-of-Venous- Thromboembolism- Additional-Performance-Measures.aspx. Accessed December 15, 2010.
3. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(suppl 4):S495-S501.
4. The burden of venous thromboembolism in Australia. Report by Access Economics Pty Limited for the Australian and New Zealand Working Party on the Management and Prevention of Venous Thromboembolism. The Murray-Plains Division of General Practice Web site. http://www.mpdgp.com.au/files/ docs/laos%20recommendations/prevention%20of%20venus %20thromboembolism/ the%20burden%20of%20venous% 20thromboembolism%20in%20australia.%20access%20 economics.pdf. 2008 May. Accessed June 1, 2011.
5. Cohen AT, Agnelli G, Anderson FA, et al. VTE Impact Assessment Group in Europe (VITAE). Venous thrombo-embolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007; 98(4):756-764. (Pubitemid 47555066)
6. Cohen AT. The burden of venous thromboembolism in the hospital setting. Pathophysiol Haemost Thromb. 2009-2010; 37(suppl 1):102.
7. Cohen AT, Tapson VF, Bergmann JF, et al. ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387-394. (Pubitemid 351173321)
8. Cohen AT. Prevention of postoperative venous thromboembolism. BMJ. 2009;339:b4477.
9. Schultz DJ, Brasel KJ, Washington L, et al. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. J Trauma. 2004;56(4):727-731.
10. Cook DJ, Crowther MA. Thromboprophylaxis in the intensive care unit: focus on medical-surgical patients. Crit Care Med. 2010;38(suppl 2):S76-S82.
11. Geerts WH, Bergqvist D, Pineo GF, et al. American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133 (suppl 6):381S-453S. (Pubitemid 351894916)
12. Joint Commission International. Venous Thromboembolism (VTE) measures. Joint Commission International Web site. http://www. jointcommissioninternational.org/common/PDFs/ JCI%20Standards/International- Library-of-Measures/VTE- Measures-and-Details-090810.pdf. Accessed December 24, 2010.
13. Kakkar AK, Davidson BL, Haas SK; Investigators Against Thromboembolism (INATE) Core Group. Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines. J Thromb Haemost. 2004;2(2):221-227. (Pubitemid 40186034)
14. Ginzburg E, Dujardin F. Physicians' perceptions of the definition of major bleeding in major orthopedic surgery: results of an international survey. J Thromb Thrombolysis.2011;31(2):188-195.
15. Tapson VF, Decousus H, Pini M, et al. IMPROVE Investigators. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007;132(3):936-945.
16. Steele N, Dodenhoff RM, Ward AJ, Morse MH. Thromboprophylaxis in pelvic and acetabular trauma surgery. The role of early treatment with low-molecular-weight heparin. J Bone Joint Surg Br. 2005;87(2):209-212.
17. Nathens AB, McMurray MK, Cuschieri J, et al. The practice of venous thromboembolism prophylaxis in the major trauma patient. J Trauma. 2007;62(3):557-562. (Pubitemid 46568849)
18. Australian and New Zealand Intensive Care Society. Database Management Committee. Australian and New Zealand Intensive Care Society Web site. http://www.anzics.com.au/ downloads/doc-download/169-anzics-core-terms-of- reference %20anzics%20core%20terms%20of%20reference. Accessed December 15, 2010.
19. Ho KM, Tan JA. Use of L'Abbé and pooled calibration plots to assess the relationship between severity of illness and effectiveness in studies of corticosteroids for severe sepsis. Br J Anaesth. 2011;106(4):528-536.
20. Kucher N, Tapson VF, Goldhaber SZ; DVT FREE Steering Committee. Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb Haemost. 2005;93(3):494-498. (Pubitemid 40392538)
21. Ho KM, Burrell M, Rao S, Baker R. Incidence and risk factors for fatal pulmonary embolism after major trauma: a nested cohort study. Br J Anaesth. 2010;105(5):596-602.
22. Robertson MS, Nichol AD, Higgins AM, et al. VTE Point Prevalence Investigators for the Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Society Clinical Trials Group. Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units. Crit Care Resusc. 2010;12(1):9-15.
23. Nendaz MR, Chopard P, Lovis C, et al. Adequacy of venous thromboprophylaxis in acutely ill medical patients (IMPART): multisite comparison of different clinical decision support systems. J Thromb Haemost. 2010;8(6):1230-1234.
24. Goldhaber SZ. Eradication of hospital-acquired venous thromboembolism. Thromb Haemost. 2010;104(6):1089-1092.
25. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005;352(10):969-977.
26. Williams TA, Knuiman MW, Finn JC, Ho KM, Dobb GJ, Webb SA. Effect of an episode of critical illness on subsequent hospitalisation: a linked data study. Anaesthesia. 2010;65(2):172-177.
27. Ashrani AA, Heit JA. Incidence and cost burden of postthrombotic syndrome. J Thromb Thrombolysis. 2009;28(4):465-476.
28. Limpus A, Chaboyer W, McDonald E, Thalib L. Mechanical thromboprophylaxis in critically ill patients: a systematic review and meta-analysis. Am J Crit Care. 2006;15(4):402-412. (Pubitemid 44859181)
29. Chiasson TC, Manns BJ, Stelfox HT. An economic evaluation of venous thromboembolism prophylaxis strategies in critically ill trauma patients at risk of bleeding. PLoS Med.2009;6(6):e1000098.